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In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster C. Abels', P. Hei12, M. Dellian', G.E.H. Kuhnle Summan For successful photodynamic diagnosis (PDD) and effective photodymamic therapy (PDT) with the clinically used 'photosensitiser' 5-aminolaevulinic acid (ALA) . knowledge of the maximal fluorescence intensity and of the maximal tumour-host tissue fluorescence ratio following systemic or local application is required. Therefore, time course and type of porphyrin accumulation were investigated in neoplastic and surrounding host tissue by measuring the kinetics and spectra of ALA-induced fluorescence in vivo Experiments were performed in the amelanotic melanoma A-Mel-3 grown in the dorsal skinfold chamber preparation of Syrian golden hamsters. The kinetics of fluorescent porphyrins was quantified up to 24 h after i.v. injection of 100 mg kg-'. 500 mg kg-' or 1.000 mg kg-' body weight ALA by intravital fluorescence microscopy and digital image analysis (n = 18). In separate experiments fluorescence spectra were obtained for each dose by a simultaneous optical multichannel analysing device (n = 3). A three-compartment model was developed to simulate fluorescence kinetics in tumours. Maximal fluorescence intensity (per cent of reference standard;
mean±s.e.) in the tumour arose 150min post injection (p.i.) (I.000mgkg-'. 109±34%;: 500mgkg-', 148 ± 36%) and 120 min p.i. (100 mg kg-'. 16 ± 8%). The fluorescence in the surrounding host tissue was far less and reached its maximum at 240 min (100 mg kg-'. 6 ± 3%) and 360 min p.i. (500 mg kg-'. 50 ± 8%) and (1.000 mg kg-'. 6 ± 19%). Maximal tumour -host tissue ratio (90:1) was encountered at 90 mn after injection of 500 mg kg-'. The spectra of tissue fluorescence showed maxima at 637 nm and 704 nm respectively After 300 min (host tissue) and 360 min (tumour tissue) additional emission bands at 618 nm and 678 nm were detected. These bands indicate the presence of protoporphyrin IX (PPIX) and of another porphyrin species in the tumour not identified yet. Tumour selectivity of ALA-induced PPIX accumulation occurs only during a distinct interval depending on the administered dose. Based on the presented data the optimal time for PDD and PDT in this model following intravenous administration of 500 mg kg-' ALA would be around 90 min and 150 min respectively. The transient selectivity is probably caused by an earlier and higher uptake of ALA in the neoplastic tissue most likely as a result of increased vascular permeability of tumours as supported by the mathematical model.
In 1955 the first report on transitory hypersensitivity to sunlight following exogenous administration of 5-aminolaevulinic acid (ALA) was published (Scott. 1955) . By injecting ALA subcutaneously into the back of rats Jarret et al. (1956) could support this observation. In addition, Berlin et al. (1956a,b) described light hypersensitivity after ingestion of ALA by human subjects to study the metabolism of ALA. At that time preferential localisation of porphyrins in neoplasms of tumour-bearing animals and subsequent photodynamic reactions due to light irradiation had already been shown (Policard, 1924 : Auler & Banzer, 1942 (Williams, 1990) . The rate-limiting step in endogenous porphyrin production, i.e. formation of ALA, is bypassed when ALA is either given systemically or applied locally in excess amount (Kennedy et al., 1990; Kennedy & Pottier, 1992; del C. Batile, 1993) . Subsequently, depending on the cells' enzyme proffle, the intracellular accumulation of photosensitising porphyrins occurs (Pottier et al., 1986 , Divan's et al., 1990 Kennedy et al., 1990; Loh et al., 1992 Loh et al., , 1993 , providing the basis for photodynamic diagnosis and treatment of superficial malignancies.
ALA-induced fluorescence and accumulation of photosensitising porphyrins are already used clinically for photodynamic diagnosis (PDD) and therapy (PDT) of various tumours (Kennedy et al., 1990; Wolf & Kerl, 1991 : Baumgartner et al., 1993 Grant et al., 1993; Wolf et al., 1993) . However, the kinetics of ALA-induced fluorescence in tumours has not yet been studied in vivo.
So far, ALA-induced fluorescence has been measured in histological sections of normal colon and of a colon carcinoma showing high mucosa fluorescence (Bedwell et al., 1992) . The kinetics has also been determined ex vivo by porphyrin extraction from a mammary carcinoma (Peng et al., 1992) . Moreover, PDD and PDT have been performed using the induced porphyrins without knowledge of the time course of fluorescence intensity in neoplastic tissue and of the optimal tumour-surrounding tissue fluorescence ratio (Divaris et al., 1990; Kennedy et al., 1990; Bedwell et al.. 1992; Wolf et al., 1993) . This could be an explanation for heterogeneous responses to PDT with ALA or different tumour types reported so far (Wolf et al., 1993) . The importance of further investigations of ALA-induced fluorescence kinetics is emphasised in order to determine the optimal time for PDT (Szeimis et al., 1994) . Therefore a model allowing in vivo investigation in conscious tumour-bearing animals over a prolonged time (Endrich et al., 1980) chamber. Injection of cells was performed 48 h after surgical preparation of the chambers, when they showed an intact microcirculation (for details see Endrich et al., 1979; Endrich et al., 1980 , Asaishi et al., 1981 . The host tissue consists of a thin skin muscle, subcutaneous adipose tissue and dermis (Endrich et al., 1980) . Six to eight days later fluorescence microscopy and spectroscopy were performed when a nonhaemorrhagic tumour was established (mean tumour diameter 6mm). Twenty-four hours before the injection of ALA permanent indwelling catheters (PE 10, inner diameter 0.28 mm) were implanted under anesthesia (pentobarbital, 50 mg kg-' b.w.) into the right jugular vein. Twenty-one animals were included in the study.
Preparation and administration of ALA ALA as the hydrochloride salt (MW 168) was obtained from Merck (Darmstadt, Germany), dissolved in phosphatebuffered saline (pH 6.5) at a concentration of 100mg ml-' and used immediately. ALA was mini intravenously in doses of I00 mg kg-', 500 mg kg-' or 1,000 mg kg-' b.w.
The conscious animal did not show any signs of discomfort during injection of the buffered solution as previously reported by Edwards et al. (1984) .
In vivo fluorescence microscopy The conscious hamster was positioned in a Perspex tube on a custom-made stage (Effenberger, Munich, Germany) under a modified Leitz microscope (Orthoplan, Type 307-143003/ 51466, Leitz, Munich, Germany). To enable subtraction of tissue autofluorescence intravital microscopy was performed before intravenous injection of ALA (n = 6 for each dose). At 1, 5, 15, 30, 45, 60, 90, 120, 150, 180, 240 , 300 and 360min and 24h after injection ALA-induced fluorescence was registered.
Fluorescence was excited at 355-425 nm for 2 s at a power density of 200-300 #Wcm-2 (100 W HBO mercury lamp) measured by a wavelength-correcting diode detector ('Labmaster', Coherent, Auburn, USA). Emission fluorescence was detected above 610 nm. Fluorescence images were recorded by a silicon-intensified target video camera (C2400-08, Hamamatsu, Herrsching, Germany), which was previously calibrated to assure linearity by measunng emitted fluorence of used standard (Impregum F, Seefed Germany) through different grey filters at all sensitivity levels of the camera. Acquired fluorescence images were digitally integrated by an image analysis system and stored on hard disk (IBAS 2000, Kontron, Eching, Germany 
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In vivo fluorescence microscopy Time (h) (Table I) . Fluorescence in the surrounding host tissue was far less than in the tumour, reaching a maximum after 240 min (6 ± 3%. 100 mg kg-') and 360 min p.i.
(68± 19%, l000mgkg-'; 50+ 8%, 500mgkg-'). The highest absolute fluorescence in surrounding tissue was measured after 1,000 mg kg-' b.w.
Fluorescence decreased constantly after reaching the maximum and was barely detectable after 24 h p.i. either in the tumour (0.8 ± 0.8%, 100 mg kg-'; 2.2 ± 1.7%, 500 mg kg-'; 9.7 ± 2.2%. 1.000 mg kg-') or in the surrounding host tissue (0.9±0.9%. l00mgkg-'; 1.4+0.7%. 50Omgkg-'; 8.9±4.2%, l,000mgkg-').
For optimal diagnosis or effective therapy of malignancies in our model, tumour-host tissue ratios were calculated for the administered doses (Figure 2 ). The optimal ratio was found at 60min for 100mg kg-', at 90min for 500mg kg-' and at 120 min for 1000 mg kg-'. The maximal tumour-normal tissue ratio was calculated for 500 mg kg-' as 90:1. Ratios obtained after injection of 100 mg kg-' and 1.000 mg kg-' were 12:1 and 78:1 respectively (Table I) .
The maximal fluorescence intensities indicating the highest sensitiser concentration in tumour and surrounding host tissue are shown in Table I (Figure 1 ), but also within tumours shown in the fluorescence images ( Figure   3 ).
In vivofluorescence spectroscopy
The emission spectra from the tumour exhibited spectral emission bands with maxima at 637 and 704 nm ( Figure 4 Moreover, peaks at 618 nm and 678 nm arose at 360 min following ALA injection in the tumour and at 300 min in the host tissue, indicating the presence of another fluorescent compound (Figure 4 ).
For the first time the in vivo fluorescence kinetics together with the spectral characteristics of ALA-induced endogenous porphyrin accumulation in tumour and surrounding host tissue have been measured. The determination of the exact time course of porphyrin fluorescence in tumours is the basis for effective PDD and PDT, making use of the highest fluorescence intensity in neoplastic tissue and the optimal tumour-host tissue fluorescence ratio. In addition, elucidation of the underlying mechanism that leads to tumour selectivity might result in a fundamental improvement in this therapeutic modality.
Intravital microscopy of tumours grown in transparent skin chambers is a highly valuable, established method for the study of photosensitiser localisation kinetics (Leunig et al., 1993) . Using this model photosensitising drugs can be visualised not only directly at the microscopic level by their specific fluorescence emission but also without artifacts caused by sacrificing the animals for ex vivo investigation. Continuous in vivo measurements of fluorescence in the identical tumour are in particular advantageous using an endogenous photosensitiser, which might be formed at varying times and in varying amounts in different tumours of the same type. Linear correlation of fluorescence intensity and drug concentration in the tissue is a prerequisite guaranteed in this model because of the optical characteristics of the flat, well-demarcated tumour and the optical systems used (Armenante et al., 1991; Leunig et al., 1993) .
For systemic administration of ALA it is necessary to buffer the solution since higher volumes of an acidic solution might alter systemic blood pH, which may result in a change in photosensitiser uptake in tumour cells (Benet & Sheiner, 1980; Brault, 1990 ). In addition buffering the solution will prevent severe pain in the conscious hamster as well as hypotension and bradycardia (Edwards et al.. 1984 ). Concer- Nevertheless, a general decreased capacity of the amelanotic melanoma to synthesise protoporphyrin IX has not been excluded. However, Rebeiz et al. (1991) have shown that rapidly growing and multiplying cells such as A-Mel-3 tend to accumulate more tetrapyrroles owing to an increased demand for haem for cytochrome formation.
The recorded emission spectra of tumour and host tissue show the typical emission bands of protoporphyrin XI in tissue with maxima at 637 and 704 nm being in accordance with the literature (Divaris et al., 1990; Bedwell et al., 1992; Kennedy & Pottier, 1992; Loh et al., 1993) . Interestingly, after 5 h new peaks arose in the host tissue at 618 nm and 678 nm, respectively, after administration of 500 mg kg-' and 1,000 mg kg-' b.w. and appeared also in the tumour at 360 min (Figure 4 ). This might reflect the formation of another fluorescent compound, probably uro-or coproporphyrin, not yet identified. It has been shown that the amount and type of porphyrin formed varies depending on the cell line (C. Fritsch, personal communication) . Whether this new porphyrin is synthesised in the amelanotic melanoma, in the surrounding host tissue or elsewhere in the organism has not yet been determined.
In the amelanotic melanoma tissue porphyrin fluorescence was registered as early as 15 min p.i. Peng et al. (1992) could extract PPIX from a mammary carcinoma 1 h after peritoneal injection of ALA. However, they did not investigate porphyrin accumulation at earlier times. Three hours after ALA injection they found that the porphyrin content was already mark-edly decreased, thus probably missing the period of highest PPIX concentrations in neoplastic tissue between I h and 3 h, as we have shown. In our model the highest host tissue fluorescence was found at 4 h p.i.
(100mgkg-1) and 6hp.i. (500 and 1,000mgkg-'). A delayed maximum fluorescence intensity in normal tissue as compared with neoplastic tissue was also observed in the study of Bedwell et al. (1992) . They found maximal fluorescence intensity in normal colon 4 h after intravenous injection of ALA. Also, porphyrin extraction of surrounding normal skin revealed a later maximum of PPIX than in the mammary carcnoma (Peng et al., 1992) .
In amelanotic melanoma, as in other tumours, structural peculiarities of microvessels, such as holes in the endothelial lining, discontinuous basal membrane and direct contact of tumour cells with the microvascular lumen (Hammersen et al., 1983) , are associated with high transcapillary filtration compared with normal microvasculature (Endrich et al., 1983 in plasma. This is because of the enhanced permeability of tumour microvessels (Jain, 1987) . Thus, it seems very likely that the earlier appearance of fluorescence in tumours is mainly the result of a faster exchange of ALA, a five-carbon amino acid, from the intravascular into the interstitial space and consequently earlier uptake into tumour cells than in host cells. Since a considerable amount of ALA is rapidly excreted in the urine (Berlin et al., 1956a.b) and taken up by organs with a high metabolic activity for ALA, such as liver or kidney (Shimizu et al., 1978) , plasma levels will decrease rapidly. The higher fluorescence values in the tumour as compared with the surrounding host tissue might thus reflect the faster uptake of ALA in neoplastic cells at times of higher intravascular concentrations. As mentioned above, the plasma level of ALA decreases with time. Thus less fluorescence will be formed in host tissue in vivo than could be synthesised from a given dose of ALA in cell culture experiments simulating a constant plasma level. Also, Nugent and Jain (1984) have shown that small molecules (sodium fluorescein, MW 376) such as ALA have higher diffusion coefficients in neoplastic tissue than in normal tissue. Thus, it is not surprising that the highest absolute fluorescence measured in the surrounding host tissue is less (Table I ) than in neoplastic tissue with its higher vascular permeability and higher diffusivity (Gerlowski & Jain, 1986 ).
Based upon the in vitro model proposed by Jacques et al. (1993) , for the first time a mathematical model has been developed ( Figure 5 ) simulating in vivo fluorescence kinetics by using least-square fits and a Marquardt algorithm (Bevington, 1969 ). This improved model best fitted the fluorescence kinetics of ALA-induced porphyrins in the wellvascularised and fast-growing amelanotic hamster melanoma (Dellian et al., 1993) : a solid tumour is a pathophysiological entity consisting of at least three compartments, namely vasculature, interstitium and tumour cells (Ribbert, 1904; 1991). Therefore a systemically administered anti-tumour drug will reach its target after distnrbution in the intravascular space, by transport across the microvascular wall into the interstitial space (invasion constant ko) and by transport across the cell membrane into the tumour cells (invasion MO=-
. .
-ir -r -r-constant k,). Consequently. these invasion processes (white arrows in Figure 5 ) lead to increasing concentrations of porphyrins in neoplastic tissue after administration of ALA. Once administered as a bolus, ALA is taken up particularly by liver and kidney (Berlin et al., 1956a,b; Shimizu et al., 1978) (evasion constant kr), resulting in decreasing plasma concentration. The PPIX formed in the tumour is also eliminated (evasion constant kA). Both mechanisms yield reduced cellular levels of PPIX indicated by the black arrows in Figure 5 . It is assumed that elimination of ALA from intravascular space is mainly governed by kA AA(O) = Mo eAit (1) where M is the concentration of ALA in the intravascular space at time t and M0 is the ALA concentration following intravenous administration after reaching equilibrium. Because of this assumption k,, could not be calculated. Inserting equation (1), which reflects the elimination of ALA from the intravascular space by uptake into other organs and excretion, into the differential equation (2) leads to equation (3):
[e kxt e-l where M, is the assumed concentration of ALA in the interstitial space at time t, being 0 at t =0. Considering the transport of the molecules from the interstitial into the intracellular space and subsequent formation of PPIX (equation 4) the final equation (5) 
P(t) = k (e-xt -e-k2) +-e 2 (e -elk)J (5) k1 -k.k -k, k -k, where P is the concentration of PPIX in neoplastic cells at time t, with P(O) = 0. Since ALA does not fluoresce, only the formed fluorescent porphyrins will be observed by intravital microscopy. Moreover, the invasion constant k1 results from transport into the cell, transport into mitochondria and subsequent metabolisation to PPIX. As shown in Figure 6 , this three-compartment model (equation 5) yield a better curve fit than the initial compartment model proposed by Jacques et al. (1993) assuming decreasing intravascular ALA concentration (equation 3). 
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The mechanism of elimination of PPIX from the cells is not yet clear. A reduced activity of the converting enzyme ferrochelatase in tumour cells would result in a slow elimination of PPIX from neoplastic tissue, reflected by a small evasion constant k2 (Table II) . Subsequently, porphyrins would be retained in the tumour. forning a later and higher maximum of fluorescence in neoplastic than in surrounding host tissue (Figure 6 ). However, the kinetics of ALA-induced PPIX accumulation exhibits a very early maximum of fluorescence in the amelanotic melanoma and a rapid decrease in intensity before the fluorescence maximum in the surrounding host tissue is reached (Figure 1) .
Therefore one cannot conclude from the presented data that earlier and greater formation of ALA-induced endogenous fluorescence in neoplastic tissue is a specific effect because of a reduced activity of the PPIX converting enzyme ferrochelatase in neoplastic tissue, as discussed elsewhere (Dailey & Smith. 1984; del C. Battle, 1993) .
Moreover. the accumulation of porphyrins in tumours following systemic administration of ALA is mainly due to the higher vascular permeability and diffusivity of neoplastic tissue in general. Following topical application of ALA accumulation of porphyrins in tumours might be due to not only abnormal keratin overlying basal and squamous cell carcinomas (Kennedy & Pottier, 1992) , yielding reduced mechanical resistance, but also to lower interstitial resistance to the transport of molecules in neoplastic tissue (Nugent & Jain, 1984) .
Marked differences in fluorescence intensities are also visible within tumours (Figure 3) . In contrast to exogenous photosensitisers, ALA-induced photosensitising porphyrins are formed within the tumour. Besides the regional morphological differences in a tumour there is also regional heterogeneity of oxygen. blood flow, energy phosphates and pH (Endrich et al.. 1979; Vaupel et al., 1989; Kuhnle et al., 1992) determining the metabolic microenvironment, which might result in heterogeneous uptake and metabolism of ALA in a tumour. A diminished activity of the protoporphyrin IX converting enzyme ferrochelatase in tumours or metastases has been proposed to be responsible for increased porphyrin concentrations in neoplastic tissue (Dailey & Smith, 1984; Navone et al., 1990; Van Hillegersberg et al.. 1992; del C. Battle. 1993 (Stout & Becker. 1990) . The data regarding the capacity of different tumour types to metabolise ALA remain incomplete. and differences between various tumour types should be expected.
For the first time the kinetics and spectra of ALA-induced fluorescence have been measured by quantitative intravital fluorescence microscopy in tumour and surrounding host tissue. Thus, this study provides basic information required to understand the mechanism of porphyrin formation following exogenous administration of ALA and to indicate the optimal time for effective PDD and PDT according to this model. Selective ALA-induced porphyrin fluorescence in tumours occurs only during a limited interval lasting from 15 min up to 4 h after intravenous injection of ALA and by far exceeds maximal tumour-host tissue fluorescence ratios for Photofrin II or porphycenes measured in the same model (Leunig et al., 1993) . Twenty-four hours after intravenous administration of ALA hardly any fluorescence was detectable in either the tumour or the surrounding host tissue (Figure 1 ), thus general photosensitisation of patients after systemic administration of ALA might be limited. The highest tumour-host tissue ratio was recorded after a dose of 500 mg kg-' b.w. (90:1 at 90 min). Similar high selectivity of PPXI is reported for bladder tumours determined during fluorescence excitation in the Soret band following ALA instillation into the bladder (Baumgartner et al., 1993) . Tak 
